What are the current treatment guidelines for stress urinary incontinence?

Treatment Guidelines for Stress Urinary Incontinence

Start with pelvic floor muscle training (PFMT) as first-line therapy for all women with stress urinary incontinence, as it improves continence rates and quality of life with minimal adverse effects and lower cost than other interventions. 1

Initial Conservative Management

First-Line Therapy: Pelvic Floor Muscle Training

• PFMT should be the initial treatment for all women with stress incontinence, regardless of symptom severity 1, 2
• Enhanced efficacy when combined with dynamic lumbopelvic stabilization (DLS), which adds short pelvic floor and lumbar muscle resistance training 1
• Patients receiving PFMT plus DLS demonstrate improved daytime and nighttime urine loss, reduced severity, and better quality of life at 90 days, with effects increasing over time 1
• Biofeedback can be added as adjunctive therapy to enhance PFMT effectiveness 2

Weight Loss for Obese Patients

• Weight loss combined with exercise is strongly recommended for obese women with stress incontinence 1
• This intervention improves continence outcomes with moderate-quality evidence 1

Vaginal Mechanical Devices

• Vaginal cones, pessaries, and urethral plugs are recommended as first-line options alongside PFMT 2
• These devices provide immediate symptom relief while conservative therapy takes effect 2

Critical Pitfall: Avoid Systemic Pharmacotherapy

• Do not use systemic pharmacologic therapy for stress incontinence - it has not been shown to be effective 1
• Vaginal estrogen formulations may improve stress incontinence, but transdermal estrogen patches worsen symptoms 1

Surgical Management

When to Consider Surgery

• Offer surgical intervention when conservative measures fail or symptoms are severe enough that patients prefer definitive treatment 1
• Present all viable surgical options to patients with comprehensive counseling on safety and efficacy of each approach 1

First-Line Surgical Options: Midurethral Slings

• Midurethral slings (MUS) are the recommended first-line surgical technique 1, 3
• Both retropubic and transobturator routes are effective (Evidence Level A) 1
• Single-incision slings (SIS) now have emerging long-term data showing non-inferiority to transobturator slings (Evidence Level B) 1

Specific MUS Considerations:

• Retropubic approach (TVT) shows favorable outcomes over transobturator (TOT) in specific populations: obesity, intrinsic sphincter deficiency, persistent incontinence after prior MUS, and prolapse 1
• Pre-operative counseling about mesh complications reduces patient concern, increases willingness to proceed, and improves satisfaction 1
• Inform patients about intraoperative risks, postoperative complications, and failure rates 3

Long-term SIS Outcomes:

• At minimum 54-month follow-up: 75% subjective improvement, 60.8% cure rate 1
• Complications include: recurrent UTI (5.3%), urinary retention (4.3%), pain (3.5%), mesh exposure (2.5%), de novo urgency (2.5%) 1
• Sling failure occurs in 10% of patients, with 76% of failures within 2 years 1

Alternative Surgical Options: Urethral Bulking Agents

• Consider bulking agents for patients who wish to avoid invasive surgery, desire shorter recovery, or have insufficient improvement after anti-incontinence procedures 1
• Counsel patients on the expected need for repeat injections 1
• Calcium hydroxyapatite, polydimethylsiloxane, and polyacrylamide hydrogel show persistence of effect at 73.2,83, and 96 months respectively 1
• Inadequate data exist to recommend one injectable agent over another 1

Preoperative Evaluation Requirements

Essential Preoperative Assessment

• Perform cough test prior to surgery 3
• Complete urodynamic investigation is recommended before surgical intervention 3
• Exception: For pure stress incontinence with concordant clinical findings (standardized questionnaire, positive cough test, bladder diary, post-void residual), urodynamic studies are not essential 3

Evaluation Components to Document

• Patient history and physical examination focusing on circumstances, frequency, and severity of leaks 1
• Screen for reversible causes: urinary tract infections, metabolic disorders, excess fluid intake, delirium 1
• Identify medications that may cause or worsen incontinence 1
• Measure post-void residual volume 3

Special Populations

Elderly Women

• Screen for urinary infection with test strip before treatment 3
• Obtain bladder diary and measure post-void residual volume 3
• Bulking agents particularly suited for elderly, frail, or obese patients with multiple comorbidities 4

Pregnant and Postpartum Women

• PFMT is the first-line treatment for prenatal and postnatal urinary incontinence 3
• Elective cesarean section and systematic episiotomy are not recommended for incontinence prevention 3

Emerging Therapies (Third-Line)

Vaginal Laser Therapy

• Erbium:YAG laser shows beneficial effect for mild-to-moderate stress incontinence compared to sham 5
• 62.7% cure rate (≥50% reduction in pad weight test) versus 18.2% with sham at 6 months 5
• Particularly suited for young women between childbirths and postmenopausal women 4
• Safe, outpatient procedure requiring no artificial material 4